Search Results
Sep 05, 2026, 06:00 ET Best Hair Growth Products for Men (2026): Happy Head Personalized Formulas Reviewed by Consumer365
topical solution can contain 0.3% dutasteride, up to 8% minoxidil, retinoic acid and hydrocortisone. The accompanying SuperCapsule contains 0.5 mg dutasteride, 1.25 mg minoxidil and 2,000 IU of vitamin D3.The two-part regimen uses different delivery methods. The topical formula is applied directly to
More news about: Consumer365.org
Sep 04, 2026, 13:42 ET Lupin Receives U.S. FDA Approval for Modafinil Tablets, USP
USP, 100 mg and 200 mg.The U.S. FDA has approved Lupin's Modafinil Tablets USP, 100 mg and 200
More news about: Lupin Pharmaceuticals
Sep 04, 2026, 09:00 ET ERS 2026 | Mabwell Presents Phase Ib/IIa Clinical Results of Anti-ST2 Monoclonal Antibody 9MW1911 in COPD Patients
A total of 80 participants were enrolled and randomized to receive intravenous infusions of 9MW1911 injection (at doses of 100 mg, 300 mg, 600 mg, or 900 mg) or placebo, administered every 4 weeks. The demographic characteristics were generally balanced across the 9MW1911 dose groups and the
More news about: Mabwell
Sep 04, 2026, 02:00 ET Argo Biopharma to Present Positive Phase II Updated Results of siRNA Therapeutic BW-20805 for HAE at Bradykinin Symposium 2026
decreased by 83% in the 600 mg Q24W group, 96% in the 300 mg Q24W group, and 93% in the 300 mg Q12W groupAttack-free rates over Day 29 to 169 were 50% (4/8), 75% (6/8), and 62.5% (5/8) in the 600 mg Q24W, 300 mg Q24W, and 300 mg Q12W groups, respectively. Across
More news about: Argo Biopharmaceutical Co., Ltd
Sep 03, 2026, 16:22 ET American Regent, Inc. Issues Voluntary Nationwide Recall of Three Lots of Epinephrine Injection, USP 30 mg/30 mL (1 mg/mL) Due to the Presence of Particulate Matter and Lack of Assurance of Sterility
2026 /PRNewswire/ -- American Regent, Inc. is conducting a nationwide voluntary recall of three lots of Epinephrine Injection, USP 30 mg/30 mL (1 mg/mL) multi dose vials to the consumer level. Customer complaints were received for leaking and cracked vials, resulting in lack of assurance of sterility.
More news about: American Regent, Inc.
Sep 03, 2026, 15:15 ET Legionella present in nearly 20% of water samples, new test results found
three zip codes sampled. The samples also demonstrated very low chlorine treatment residuals as well averaging only 0.12 mg/L, well below an EPA workgroup recommended level of 0.5 mg/L. The City's testing during the outbreak focused on cooling towers only, per the current regulations and policy focus. "New
More news about: Prevent Legionnaires'
Sep 03, 2026, 10:15 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
treatment of wet age-related macular degeneration (wet AMD)." The press release disclosed that change from baseline in best corrected visual acuity versus 2 mg aflibercept (Regeneron Pharmaceuticals' (REGN) Eylea) was not met in the entire dataset. On this news, EyePoint's stock price fell $9.88 per share,
More news about: Pomerantz LLP
Sep 03, 2026, 10:00 ET MOJO® ENERGY POUCHES NAMED OFFICIAL ENERGY POUCH OF THE PROFESSIONAL PICKLEBALL ASSOCIATION
to the growing pickleball community."Mojo® Energy Pouches deliver a portable alternative to traditional energy formats, with options of 50mg and 100mg of caffeine per pouch and caffeine naturally derived from Green Tea, B-Vitamins, Ginseng, L-Theanine, and Yerba Mate. With zero sugar and zero calories,
More news about: Mojo Energy Pouches
Sep 03, 2026, 08:00 ET Triquetra Health Launches Saffron Kids™--First USDA Organic Sargol-Grade Saffron Extract Studied in Children at the Label Dose
protects heat-sensitive crocins from degradation. The formulation delivers 30 mg per daily serving for ages 7 through 17—matching the exact daily amount used in the published pediatric clinical trial—with a body-weight-scaled 15 mg dose for ages 3 through 6. The calibrated dropper covers ages 3 through 17
More news about: Triquetra Health LLC
Sep 03, 2026, 07:00 ET Insmed to Present Data Across Its Respiratory Portfolio, Including New Late-Breaking ARIKAYCE® (amikacin liposome inhalation suspension) Results From Phase 3b ENCORE Study at the European Respiratory Society Congress 2026
was 2.5%, 4.1%, and 4.0% in patients treated with placebo and BRINSUPRI 10 mg and 25 mg, respectively. Skin CancersIn ASPEN, the incidence of skin cancers among patients treated with BRINSUPRI 10 mg and 25 mg was 0.5% and 1.9%, respectively, compared to 1.1% in placebo-treated patients. AlopeciaIn ASPEN,
More news about: Insmed Incorporated
Sep 02, 2026, 09:09 ET /C O R R E C T I O N -- Jarrow Formulas/
protein they already consume. Jarrow Formulas® Gut & Protein Optimizer retails for $29.99 SRP.NMN 300 mgJarrow Formulas® NMN 300 mg delivers a clinically studied 300 mg dose of nicotinamide mononucleotide (NMN), an efficient precursor to NAD+, an essential vitamin B3 metabolite involved
More news about: Jarrow Formulas
Sep 02, 2026, 08:30 ET New HCPCS Billing Code Enables Medicare Benefit Billing of Lasix® ONYU When Furnished Incident to a Physician's Service
The pharmaceutical component of Lasix ONYU is a novel, high-concentration formulation of the diuretic furosemide, at 30 mg/mL. It comes in a pre-filled glass cartridge containing 80 mg of furosemide in 2.67 mL. The Lasix ONYU Infusor consists of two main parts: the Reusable Unit and the Disposable Unit.
More news about: SQ Innovation
Sep 01, 2026, 10:31 ET The Oral PCSK9 Inhibitor Market Enters High-Growth Phase Owing to the Approval of Merck's LIPFENDRA and the Emergence of Oral PCSK9 Inhibitor Drugs, Including, AstraZeneca's AZD0780, Aqur's AQR-008, and Others | DelveInsight
production, offering a distinct approach to sustained LDL-C reduction.Recently, in July 2026, the U.S. FDA has approved Merck's LIPFENDRA (20 mg tablets) as an adjunct to diet and exercise for lowering LDL-C in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia
More news about: DelveInsight Business Research, LLP
Sep 01, 2026, 07:30 ET Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy
MSS/pMMR metastatic colorectal cancer. Patients will be randomized to one of five arms: paxalisib at 15mg; paxalisib at 15mg plus pembrolizumab, with or without biologic; paxalisib at 30mg; paxalisib at 30mg plus pembrolizumab, with or without biologic; or a standard-of-care comparator arm. The primary endpoint
More news about: Kazia Therapeutics Limited
Sep 01, 2026, 07:15 ET Kazia Therapeutics Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in HR+ Breast Cancer
pre-treated HR+/HER2- metastatic breast cancer. Patients will be randomized to one of three arms: paxalisib at 15mg plus fulvestrant (hormone therapy), with CDK4/6 inhibitor palbociclib; paxalisib at 30mg plus fulvestrant, with palbociclib; or a standard-of-care comparator arm of fulvestrant. The primary endpoint
More news about: Kazia Therapeutics Limited
Sep 01, 2026, 07:00 ET Xentria Advances XTMAB-16 Clinical Development in Pulmonary Sarcoidosis Following FDA Feedback
trial in 39 adults with pulmonary sarcoidosis across the United States, European Union, and United Kingdom (38 completed). Patients received 2 mg/kg or 4 mg/kg administered every 2 or 4 weeks (Q2W or Q4W) during a 12-week period.Part A was designed to assess safety, tolerability, pharmacokinetics,
More news about: Xentria, Inc.
Sep 01, 2026, 07:00 ET Beyond Scalp: New study Suggests Role for Elissara® in Hair Growth
"Zeropollution®," Elissara® is backed by two clinical trials demonstrating its positive impact on scalp condition and the hair's appearance. At a daily dose of 250 mg, it is available in various formats including tablets, capsules, or softgels.Visit SuanNutra at Vitafoods Asia, in Bangkok, on September 2-4,
More news about: Monteloeder, S.L.
Sep 01, 2026, 06:30 ET Highlandia Soars to Best in Show, Leads Four-Medal Sweep at 2026 Summer PR%F Awards as Brand Launches Two New THC Elixirs
Limoncello Coast, built around bright, sun-soaked lemon. Both are available now in 750mL bottles at $28.95, delivering 10mg THC and 2mg CBD per 1.5oz serving (170mg THC / 34mg CBD per bottle), and are formulated for drinking straight, over ice, or mixed into a favorite cocktail or mocktail."We
More news about: Lifted Made
Aug 31, 2026, 10:38 ET A FIVE-MONTH-OLD BRAND MAKES HISTORY: FINNSUL REWRITES THE RULES OF WELLNESS IN REAL TIME
through cherry, lime and blue raspberry inspired by the classic red, white and blue freezer pop. Its formula includes Cognizin® citicoline, L-theanine, 150mg of natural caffeine, B vitamins and magnesium, with 0g sugar and 10 calories.For its first major creator collaboration, FINNSUL chose Mongeau
More news about: FINNSUL
Aug 31, 2026, 08:22 ET CStone 2026 Interim Results: Accelerating Pipeline 2.0 Execution and Sustained Global Commercial Momentum
with IO plus chemotherapy), CS2009 monotherapy (30 mg/kg dose level) yielded an ORR of 38.5% and a DCR of 84.6%; In patients with heavily pretreated metastatic colorectal cancer (mCRC), CS2009 monotherapy (30 mg/kg dose level) achieved an ORR of 20% and a DCR
More news about: CStone Pharmaceuticals
Aug 31, 2026, 07:30 ET Karyopharm Submits Supplemental New Drug Application to the FDA for XPOVIO® (selinexor) Plus Ruxolitinib for Patients with Myelofibrosis
NCT04562389) is a Phase 3 clinical trial evaluating a once-weekly dose of 60 mg of selinexor in combination with ruxolitinib compared to placebo plus ruxolitinib in JAKi-naïve myelofibrosis patients with platelet counts >100
More news about: Karyopharm Therapeutics Inc.
Aug 31, 2026, 07:07 ET RED BULL® BRINGS BACK FAN-FAVORITE FUJI APPLE & GINGER FLAVOR PERMANENTLY AS RED BULL APPLE EDITION
available with sugar in the United States.How much caffeine does Red Bull Apple Edition contain?The Red Bull Apple Edition contains 80 mg of caffeine per 8.4 fl oz can – about the same as a home-brewed cup of coffee, consistent with an 8.4 fl oz can of Red Bull Energy Drink.Does
More news about: Red Bull North America
Aug 31, 2026, 07:00 ET New Phase 3b data on Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults with psoriatic disease and obesity
Poison Help line at 1-800-222-1222 or go to the nearest hospital emergency room right away.Zepbound is approved as a 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg injection.Learn moreZepbound is a prescription medicine. For more information, call 1-800-LillyRx (1-800-545-5979)
More news about: Eli Lilly and Company
Aug 31, 2026, 06:00 ET IDEAYA Biosciences Announces Successful FDA Type C Meeting for IDE849, DLL3 TOP1 ADC, on Phase 3 Registrational Trial Design for Potential Accelerated and Full Approval in Extensive Stage Small Cell Lung Cancer
endpoint for potential accelerated approval and median OS as the primary endpoint for potential full approvalDose evaluation ongoing of 2.4mg/kg and 3.5 mg/kg IV Q3W to determine the RP3DTarget enrollment for the Phase 3 study will be ~400 ES-SCLC patients, randomized 1:1 treatment vs. investigator's
More news about: IDEAYA Biosciences, Inc.
Aug 31, 2026, 03:18 ET AMGEN'S REPATHA® REDUCES RISK OF DEATH IN PATIENTS AT HIGH RISK FOR A FIRST HEART ATTACK OR STROKE
level of 45 mg/dL compared to 109 mg/dL in the placebo group.VESALIUS-CV enrolled more than 12,000 patients with known ASCVD or high-risk diabetes, who had no history of heart attack or stroke, an LDL-C ≥ 90 mg/dL, or non-high-density lipoprotein cholesterol (non-HDL-C) ≥ 120 mg/dL, or apolipoprotein
More news about: Amgen